Skip to main content
Frontiers in Oncology logoLink to Frontiers in Oncology
. 2023 Sep 13;13:1278074. doi: 10.3389/fonc.2023.1278074

Corrigendum: Impressive reduction of brain metastasis radionecrosis after cabozantinib therapy in metastatic renal carcinoma: a case report and review of the literature

Jacopo Lolli 1,†, Francesca Tessari 1,†, Franco Berti 1, Marco Fusella 1,2, Davide Fiorentin 1,2, Davide Bimbatti 3, Umberto Basso 3, Fabio Busato 1,2,*,†
PMCID: PMC10543421  PMID: 37790753

In the published article, there was an error in the Funding statement as it was not specified that this research was funded by the Italian Ministry of Health Ricerca Corrente. The correct Funding statement appears below.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way.

Funding Statement

This research was funded by Italian Ministry of Health Ricerca Corrente.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.


Articles from Frontiers in Oncology are provided here courtesy of Frontiers Media SA

RESOURCES